Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol. 2024 Mar;25(3):388-399. doi: 10.1016/S1470-2045(23)00674-5.
Lancet Oncol. 2024.
PMID: 38423051
Clinical Trial.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, Schäfer-Eckart K, Burgues JMB, Steffen B, Bernal T, Krause SW, Riaza R, Schliemann C, Cervera J, Kaufmann M, Torres-Miñana L, Hänel M, Acuña-Cruz E, Jost E, Algarra JL, Crysandt M, Fransecky L, Cornago-Navascues J, Kraus S, Martinez-Lopez J, Einsele H, Niemann D, Neubauer A, Seggewiß-Bernhardt R, Scholl S, Klein SA, Schmid C, Schaich M, Schmidt-Hieber M, Zukunft S, Ho AD, Platzbecker U, Baldus CD, Müller-Tidow C, Thiede C, Bornhäuser M, Serve H, Levis M, Montesinos P, Röllig C, Schlenk RF.
Kayser S, et al. Among authors: torres minana l.
Haematologica. 2023 Jan 1;108(1):34-41. doi: 10.3324/haematol.2022.281137.
Haematologica. 2023.
PMID: 35678031
Free PMC article.
Item in Clipboard
Management of acquired hemophilia A: results from the Spanish registry.
Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tàssies D, Marco-Rico A, Núñez R, García-Candel F, de Mora MF, Soto I, Álvarez-Román MT, Asenjo S, Carrasco M, Lluch-García R, Martín-Antorán JM, Rodríguez-Alén A, Roselló E, Torres-Miñana L, Marcellini-Antonio S, Moretó-Quinana A, Rodríguez-García JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernández-Mosteirín N, Martínez-Badás MP, Pérez-Sánchez M, Pérez-Montes R, Rodríguez-González R, Uribe-Barrientos M, Caparrós-Miranda IS, Iglesias-Fernández M, Baena Á, Rodríguez-López M, Sebrango-Sandia A, Vázquez-Fernández I, Marco P; Acquired Haemophilia Spanish Registry of the Spanish Society of ThrombosisHaemostasis (SETH).
Mingot-Castellano ME, et al. Among authors: torres minana l.
Blood Adv. 2021 Oct 12;5(19):3821-3829. doi: 10.1182/bloodadvances.2021004626.
Blood Adv. 2021.
PMID: 34521101
Free PMC article.
Item in Clipboard
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
Boluda B, Solana-Altabella A, Cano I, Martínez-Cuadrón D, Acuña-Cruz E, Torres-Miñana L, Rodríguez-Veiga R, Navarro-Vicente I, Martínez-Campuzano D, García-Ruiz R, Lloret P, Asensi P, Osa-Sáez A, Aguero J, Rodríguez-Serrano M, Buendía-Fuentes F, Megías-Vericat JE, Martín-Herreros B, Barragán E, Sargas C, Salas M, Wooddell M, Dharmani C, Sanz MA, De la Rubia J, Montesinos P.
Boluda B, et al. Among authors: torres minana l.
Cancers (Basel). 2023 Apr 12;15(8):2267. doi: 10.3390/cancers15082267.
Cancers (Basel). 2023.
PMID: 37190195
Free PMC article.
Item in Clipboard
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
Solana-Altabella A, Megías-Vericat JE, Ballesta-López O, Boluda B, Cano I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Sargas C, Sanz MÁ, Borrell-García C, López-Briz E, Poveda-Andrés JL, De la Rubia J, Montesinos P, Martínez-Cuadrón D.
Solana-Altabella A, et al. Among authors: torres minana l.
Cancers (Basel). 2022 Apr 11;14(8):1921. doi: 10.3390/cancers14081921.
Cancers (Basel). 2022.
PMID: 35454828
Free PMC article.
Item in Clipboard
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Martínez Sánchez MP, Megías-Vericat JE, Rodríguez-Veiga R, Vives S, Bergua JM, Torrent A, Suárez-Varela S, Boluda B, Martínez-López J, Cano-Ferri I, Acuña-Cruz E, Torres-Miñana L, Martín-Herreros B, Serrano A, Sempere A, Barragán E, Sargas C, Sanz M, Martínez-Cuadrón D, Montesinos P; PETHEMA group.
Martínez Sánchez MP, et al. Among authors: torres minana l.
Ann Hematol. 2021 Jun;100(6):1497-1508. doi: 10.1007/s00277-021-04542-8. Epub 2021 Apr 29.
Ann Hematol. 2021.
PMID: 33914097
Clinical Trial.
Item in Clipboard
Cite
Cite